Purchase Order 36C26226P0167
- Not listed
- This is a firm fixed price purchase order contract awarded by the Department of Veterans Affairs (VA) to Diagnostica Stago Inc. for coagulation testing equipment, reagents, and related services. The $1,122,770.74 contract supports the VA's Veterans Integrated Service Network (VISN) 22 and has a completion date of December 30, 2025. Diagnostica Stago, a manufacturer of hemostasis and thrombosis testing products, will provide its STA line of coagulation analyzers, specialty reagents and...
- This federal contract award to Diagnostica Stago Inc. is for the provision of coagulation equipment and reagents to the U.S. Department of Veterans Affairs (VA). The $182,536.65 firm fixed price purchase order falls under the VA's Veterans Integrated Service Network (VISN) regional healthcare system. Diagnostica Stago is an experienced prime contractor delivering coagulation testing capabilities, such as prothrombin time, partial thromboplastin time, fibrinogen, and D-dimer tests, to support...
- The Department of Veterans Affairs, Veterans Integrated Service Network (VISN) 16, awarded a delivery order valued at $9,537.70 to Diagnostica Stago Inc. on May 27, 2021, under a VISN-wide Blanket Purchase Agreement (BPA) for coagulation testing instrumentation, reagents, and supplies. This firm fixed-price delivery order, which was set to conclude on May 26, 2022, was issued under the General Services Administration (GSA) Schedule 66-III for Critical Analyzers, Laboratory Equipment and...
- The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 4, awarded a $87.7K firm fixed-price Blanket Purchase Agreement (BPA) call to Diagnostica Stago Inc. for coagulation testing supplies and services. The contract, which commenced on September 1, 2025, with completion targeted for February 28, 2026, was issued without set-aside designation under the GSA Schedule 66-III (Critical Analyzers, Laboratory Equipment and Supplies). Diagnostica Stago Inc., a foreign-owned medical...
- The U.S. Department of Veterans Affairs (VA) awarded a firm fixed price Blanket Purchase Agreement (BPA) call to Diagnostica Stago Inc., a manufacturer of medical devices and consumables for hemostasis and thrombosis testing. The $75,984.23 contract provides the VA's Veterans Integrated Service Network (VISN) 19 with coagulation analyzers, reagents, controls, and associated products to support clinical laboratory operations and patient care at VA medical facilities. As a prime contractor,...
- The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 4, awarded a $67,013.55 firm fixed-price Blanket Purchase Agreement call to Diagnostica Stago Inc. for coagulation testing products and services. This contract, effective through February 28, 2026, was awarded on September 1, 2025, with no set-aside designation and will be performed in Philadelphia, Pennsylvania. The award falls under the GSA Schedule 66-III for Critical Analyzers and Laboratory Equipment and...
- Diagnostica Stago Inc., a foreign-owned manufacturer of hemostasis and thrombosis testing technologies, received a Blanket Purchase Agreement (BPA) call award from the Department of Veterans Affairs' Veterans Integrated Service Network 16 on July 1, 2024. The contract, with a ceiling value of $2,328.04 and a firm fixed price structure, is for the provision of coagulation testing instrumentation, reagents, and supplies to support clinical laboratory operations at VA medical facilities. The...
- Diagnostica Stago Inc., a foreign-owned medical device manufacturer specializing in hemostasis and thrombosis testing technologies, was awarded a Blanket Purchase Agreement call valued at $25,171.58 by the Department of Veterans Affairs' Veterans Integrated Service Network 4 on September 1, 2025. The contract, structured under GSA Schedule 66-III (Critical Analyzers, Laboratory Equipment and Supplies), carries a firm fixed price and is scheduled for ultimate completion on February 28, 2026....
- The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded a firm fixed price Blanket Purchase Agreement (BPA) Call for $138,985.16 to Diagnostica Stago Inc., a foreign-owned for-profit manufacturer of medical devices and consumables for coagulation testing. The contract is under the VA's VISN 20 regional network and provides coagulation lab testing services, including prothrombin time, partial thromboplastin time, fibrinogen, and D-dimer testing, to support clinical...
- The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 4, awarded a $11,635.74 firm fixed-price call under a Blanket Purchase Agreement to Diagnostica Stago Inc. on September 1, 2024, for coagulation testing products and services. The contract is not set-aside and falls under GSA Schedule 66-III (Critical Analyzers, Laboratory Equipment and Supplies), with performance at the awardee's location in Erie, Pennsylvania, and completion targeted for August 31, 2025. Diagnostica...
The Department of Veterans Affairs, Veterans Integrated Service Network 22, awarded a $413,397 firm fixed-price purchase order to Diagnostica Stago Inc. for coagulation testing products and services, with a completion date of June 30, 2026. This contract represents a direct procurement without set-aside designations, supporting clinical laboratory operations at VA medical facilities in California. Diagnostica Stago Inc., a medical device manufacturer headquartered in Parsippany, New Jersey, specializes in hemostasis and thrombosis testing technologies, including the STA series of automated coagulation analyzers and associated reagents, controls, and maintenance services used for prothrombin time, partial thromboplastin time, fibrinogen, and D-dimer assessments. This purchase order likely draws from or supports existing blanket purchase agreements between Diagnostica Stago and the VA, as the company maintains significant indefinite delivery vehicles with multiple VISN networks, including a $3.5 million BPA with VISN 6 and a $3.9 million BPA with VISN 17. These contracts enable rapid procurement of specialized coagulation testing capabilities essential for evaluating bleeding disorders, anticoagulation therapy management, and thrombosis risk assessment across the VA healthcare system. The vendor's consistent contract performance and technical expertise in federal healthcare diagnostics positions it as a key supplier for VA laboratory operations and patient care initiatives.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $413.4k | 11/17/25 |